Ventas price target raised to $55 from $52 at Scotiabank

Scotiabank raised the firm’s price target on Ventas to $55 from $52 and keeps a Sector Perform rating on the shares. The supply and demand imbalance across the U.S. Seniors Housing industry should support a strong occupancy runway for years to come in the U.S. Healthcare REITs sector, the analyst tells investors. The firm is raising its price targets to reflect a recent move higher in the sector’s multiple and expects Ventas to continue to trade at the high end of 5-year historical multiple spreads.